Greater Cincinnati firm faces lawsuits linked to FDA warning, stock dip

Several law firms are advertising for clients related to a class-action lawsuit recently filed against Meridian Bioscience following a dip in stock price last year.   The value of the stock shifted after a division of Greater Cincinnati’s 25th-largest public company was cited for alleged violations by a federal agency. Shares in the Newtown-based maker of clinical diagnostic test kits (NASDAQ: VIVO) were trading at $15.30 this afternoon, up more than 1 per cent from the previous close of $15.10.…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news